Home

Caplin Point Laboratories Ltd PE Ratio

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

PE

30

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Caplin Point Laboratories Ltd is 30 as of 22 Feb 12:04 PM .
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 9.9 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 17.21% over 5 years.
  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 2030 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Caplin Point Laboratories Ltd

No data available

Company Fundamentals for Caplin Point Laboratories Ltd

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

Share Price

₹ 2030.1

-20.35 (-0.99%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Caplin Point Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Caplin Point Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20252030.1
20 Feb 20252050.45
19 Feb 20252023.45
18 Feb 20251930.1
17 Feb 20251983
14 Feb 20251915.65
13 Feb 20252013.5
12 Feb 20252063.65
11 Feb 20252035.6
10 Feb 20252122.8

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Caplin Point Laboratories Ltd

Asset Value vs Market Value of Caplin Point Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Caplin Point Laboratories Ltd15431
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Caplin Point Laboratories Ltd Explained

15431

Market cap

515

Earnings

30.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Caplin Point Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Caplin Point Laboratories Ltd

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

Caplin Point Laboratories Ltd News Hub

Volumes spurt at Caplin Point Laboratories Ltd counter

Hindustan Zinc Ltd, Godfrey Phillips India Ltd, Angel One Ltd, Triveni Engineering and Industries Lt

Read more

19 Aug 24

Caplin Point Laboratories Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, Godfrey Phillips India Ltd, Gravita India Ltd and Poly Medicure Ltd are am

Read more

19 Aug 24

Benchmarks trades with small gains; media shares in demand

The domestic equity benchmarks traded with decent gains in morning trade. The Nifty traded above the

Read more

19 Aug 24

Caplin Point hits life high after Chennai unit clears Brazilian Agency's inspection

ANVISA conducted an inspection of Caplin Steriles' injectable and ophthalmic manufacturing facility

Read more

19 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Caplin Point Laboratories Ltd

What is the current PE Ratio of Caplin Point Laboratories Ltd?

The Current PE Ratio of Caplin Point Laboratories Ltd is 29.95 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Caplin Point Laboratories Ltd last year?

The PE Ratio of Caplin Point Laboratories Ltd was 12.04 last year, now the PE ratio is 29.95, showing a year-on-year growth of 148.8%.

What does the PE Ratio of Caplin Point Laboratories Ltd indicate about its stock?

The PE Ratio of Caplin Point Laboratories Ltd is 29.95. This ratio indicates that investors are willing to pay 29.95 times the earnings per share for each share of Caplin Point Laboratories Ltd.

What is the PE Ratio Growth of Caplin Point Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Caplin Point Laboratories Ltd grew by 148.8% whereas, the EPS ratio grew by 6.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions